161 related articles for article (PubMed ID: 30569864)
1. Supervised Machine Learning Algorithms for Evaluation of Solid Lipid Nanoparticles and Particle Size.
Öztürk AA; Gündüz AB; Ozisik O
Comb Chem High Throughput Screen; 2018; 21(9):693-699. PubMed ID: 30569864
[TBL] [Abstract][Full Text] [Related]
2. Impact of Pluronic F-68 vs Tween 80 on Fabrication and Evaluation of Acyclovir SLNs for Skin Delivery.
Bhupinder K; Newton MJ
Recent Pat Drug Deliv Formul; 2016; 10(3):207-221. PubMed ID: 27456458
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir Solid Lipid Nanoparticles for Skin Drug Delivery: Fabrication, Characterization and In vitro Study.
Bhupinder K; Newton MJ
Recent Pat Drug Deliv Formul; 2017; 11(2):132-146. PubMed ID: 28124592
[TBL] [Abstract][Full Text] [Related]
5. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
7. Budesonide-loaded solid lipid nanoparticles for pulmonary delivery: preparation, optimization, and aerodynamic behavior.
Esmaeili M; Aghajani M; Abbasalipourkabir R; Amani A
Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1964-1971. PubMed ID: 26758698
[TBL] [Abstract][Full Text] [Related]
8. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
9. In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy.
Jones E; Ojewole E; Kalhapure R; Govender T
Drug Dev Ind Pharm; 2014 May; 40(5):669-79. PubMed ID: 24576267
[TBL] [Abstract][Full Text] [Related]
10. Improved Method for Solid Lipid Nanoparticle Preparation Based on Hot Microemulsions: Preparation, Characterization, Cytotoxicity, and Hemocompatibility Evaluation.
Kotmakçı M; Akbaba H; Erel G; Ertan G; Kantarcı G
AAPS PharmSciTech; 2017 May; 18(4):1355-1365. PubMed ID: 27502405
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
12. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
13. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
14. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique.
Shah RM; Malherbe F; Eldridge D; Palombo EA; Harding IH
J Colloid Interface Sci; 2014 Aug; 428():286-94. PubMed ID: 24910064
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies.
Sabapati M; Palei NN; C K AK; Molakpogu RB
Drug Dev Ind Pharm; 2019 Apr; 45(4):577-586. PubMed ID: 30663427
[TBL] [Abstract][Full Text] [Related]
17. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
Shah MK; Madan P; Lin S
Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
[TBL] [Abstract][Full Text] [Related]
18. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
19. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation.
Rajpoot K; Jain SK
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1236-1247. PubMed ID: 28849671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
